Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib and Metformin in Advanced Kidney Cancer
NCT02495103Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Aug 2015
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Aug 2015; status: terminated.
02
Drugs
vandetanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT02495103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495103.